Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo

Cancer Chemotherapy and Pharmacology

Volumn 53, Issue 1, 2004, Pages 43-50

  Donnelly, Erling T ^a   Kelley, Marianne ^a   Rockwell, Sara ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carboplatin; Cisplatin; Oxygen delivery; RSR13

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CISPLATIN; EFAPROXIRAL; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; CYTOTOXICITY; DRUG RESPONSE; EXPERIMENTAL MOUSE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR CELL CULTURE;

ANILINE COMPOUNDS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; OXYGEN; OXYGEN INHALATION THERAPY; PROPIONIC ACIDS; TUMOR CELLS, CULTURED;

EID: 0742321767     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0715-8     Document Type: Article

References (24)

1. Abraham DJ, Wireko FC, Randad RS (1992) Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2- methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31:9141
2. Amorino GP, Lee H, Holburn GE, Pashcal CB, Hercules SK, Shyr Y, Choy H (2001) Enhanced tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13. Radiat Res 156:294
3. Doppenberg EM, Rice MR, Alessandri B, Qian Y, Di X, Bullock R (1999) Reducing hemoglobin oxygen affinity does not increase hydroxyl radicals after acute subdural hematoma in the rat. J Neurotrauma 16:123
4. Douple EB, Richmond RC (1979) Radiosensitization of hypoxic tumor cells by cis-and trans-dichloroammineplatinum(II). Int J Radiat Oncol Biol Phys 5:1369
5. Evans D, Dice C (1993) Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53:2133
6. Grau C, Overgaard J (1988) Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiother Oncol 13:301
7. Khandelwal SR, Kavanagh BD, Lin PS, Truong QT, Lu J, Abraham DJ, Schmidt-Ullrich RK (1998) RSR13, an allosteric effector of hemoglobin, and carbogen radiosensitize FSAII and SCCVII tumors in C3H mice. Br J Cancer 79:814
8. Kleinberg L, Grossman SA, Piantadosi S, Pearlman J, Engelhard H, Lesser G, Ruffer J, Gerber M (1999) Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme. J Clin Oncol 17:2593
9. Korbelik M, Skov KA (1989) Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiat Res 119:145
10. Melvik JE, Pettersen EO (1988) Oxygen-and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro. Radiat Res 114:489
11. Moulder JE, Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10:695
12. Randad RS, Mahran MA, Mehanna AS (1991) Allosteric modifiers of hemoglobin 1: design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin affinity decreasing agents. J Med Chem 4:752
13. 2 delivery in dog muscle in situ. J Appl Phys 84:995
14. Rockwell S (1977) In vivo-in vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci 27:831
15. Rockwell S, Kelley M (1998) RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice. Radiat Oncol Investig 6:199
16. Rockwell S, Mate TP, Irvin CG, Nierenburg M (1986) Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion. Int J Radiat Oncol Biol Phys 12:1315
17. Rockwell S, Kelly M, Irvin CG (1992) Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumors. Int J Radiat Biol 6:833
18. Safo MK, Moure CM, Burnett JC, Joshi GS, Abraham DJ (2001) High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector. Protein Sci 10:951
19. Skov KA, Adomat H, Farrel NP, Matthews JB (1998) Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells. Anticancer Drug Design 13:207
20. Stratford IJ, Williamson C, Adams GE (1980) Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro. Br J Cancer 41:517
21. Sun JR, Brown JM (1993) Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 133:252
22. Teicher BA, Lazo JS, Sartorelli AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73
23. Wahr JA, Gerber MJ, Venitz J, Baliga N (2001) Allosteric modification of oxygen delivery by hemoglobin: effects of RSR13 on p50 in anesthetized patients. Anesth Analg 92:615
24. Wireko FC, Kellogg GE, Abraham DJ (1991) Allosteric modifiers of hemoglobin 2: crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34:758